ODIX

Odix s.a., Orthopaedics Device Innovation, has been incorporated in October 2020. The team of the founders, with executive position in the company, justifies of an multididisciplinary and specific expertise in the field of activity:

• Gordenne Valerie, founder & CEO, Industrial pharmacist with more than 20 years of experience in pharma industry in drug development, regulatory and manufacturing, former CSO of Mithra Pharmaceuticals; 
• Frankenne Francis, founder & CSO, Doctor in Biochemistry, at the origin of the idea of LumbaCure® project, creation of Mithra's research Department and research portfolio Management (2000 - 2012), former CEO of Belma s.a. and Themise s.a.; 
• Delcorps Xavier, founder & CFO, Master in Sport Sciences & Kinesiology with 25 years' experience in Medical Devices, Internation Business Development

Odix is developping LumbaCure®, an active medical device driven by an algorithm generating complex & specific movement leading to lumbo pelvic mobilization.The device is used by the Health Care Professional for treatment and prevention of Low Back Pain. The development phase is expected to end by mid-2025 with granting of the CE mark. The commercialization will be organized via selected distributors. The initial target market will be Europe with extension in US & Canada from H2 2029. The expected turn-over in 2029 is 21M€. A second generation of LumbaCure® device with a different positioning (public version) will warrant the future growth of the company.